Sign In
Buy ZBIO
$17.40
+0.270 (+1.58%)
At Close: Jun 03, 2026
ZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO
06:59pm, Wednesday, 09'th Apr 2025
NEW YORK , April 9, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zenas BioPharma, Inc
NEW YORK CITY, NY / ACCESS Newswire / April 8, 2025 / WHY: New York, N.Y., April 8, 2025.
Zenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 Catalyst
03:08pm, Monday, 07'th Apr 2025
Dual inhibition of CD19 and FcyRIIb leads to broader B-cell depletion coverage compared to that of other CD19 and CD20 inhibitors. Zenas BioPharma, Inc.'s topline 12-week results, from the phase 2 Moo
Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer
07:05am, Monday, 07'th Apr 2025
Dr. Laken brings over 25 years of leadership experience in research, development operations, scientific assessment and strategy Dr. Laken brings over 25 years of leadership experience in research, dev
NEW YORK, NY / ACCESS Newswire / April 6, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zenas Bi
NEW YORK CITY, NY / ACCESS Newswire / April 5, 2025 / WHY: New York, N.Y., April 5, 2025.
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quantum Computing Inc. (NASDAQ: QUBT) between March 30, 2020 an
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Game of Silks non-fungible tokens (“NFTs”), including Silks Avatar NFTs,
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zenas BioPha
NEW YORK , March 31, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zenas BioPharma, In
ZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO
02:39pm, Wednesday, 26'th Mar 2025
NEW YORK , March 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zenas BioPhar
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zenas BioPha
NEW YORK CITY, NY / ACCESS Newswire / March 24, 2025 / WHY: New York, N.Y., March 24, 2025.
NEW YORK, NY / ACCESS Newswire / March 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zenas B
NEW YORK, NY / ACCESS Newswire / March 22, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zenas B
